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Introduction
The K v 7 subfamily of voltage-gated potassium channels consists of 5 members (K v 7.1-5) each playing distinct pathophysiological roles in various cell types . K v 7.1 subunits represent the molecular basis of I Ks , a cardiac current involved in action potential repolarization, whereas K v 7.2 and K v 7.3 genes have a predominant neuronal expression.
Heteromeric assembly of K v 7.2 and K v 7.3 subunits underlies the M-current (I KM ), a subthreshold current inhibiting repetitive action potential firing. K v 7.4 channels are expressed in central auditory pathways and in inner ear sensory hair cells (Kubisch et al., 1999) , in skeletal muscle cells during myotube formation (Iannotti et al., 2013) , and in smooth muscle cells of the gastrointestinal tract (Jepps et al., 2009; Ipavec et al., 2011) . In blood vessels, K v 7.4 channels contribute to vascular reactivity to vasopressors and vasodilators (Yeung et al., 2007; Mani and Byron, 2011; Martelli et al., 2013) , and down-regulation of K v 7.4 contributes to primary and secondary hypertension (Jepps et al., 2011) . K v 7.5 subunits are expressed in neurons, showing a distribution largely overlapping those of K v 7.2 and K v 7.3, and are thought to contribute to I KM heterogeneity (Schroeder et al., 2000) ; K v 7.5 transcripts and/or proteins have been also identified in skeletal and smooth muscle cells .
Activation of K
+ currents mediated by distinct K v 7 subunit combinations is currently regarded as an effective pharmacological strategy against several human diseases, with cardiac K v 7.1 channels being potential targets for antiarrhythmics (Tamargo et al., 2004) , and neuronal K v 7.2 and K v 7.3 channels for antiepileptics and analgesics (Miceli et al., 2008) . K v 7.4-selective openers may improve hearing loss (Leitner et al., 2012) , systemic or pulmonary arterial hypertension (Mani and Byron, 2011) , urinary incontinence (Rode et al., 2010) , gastrointestinal (Jepps et al., 2009; Ipavec et al., 2011) and neuropsychiatric (Hansen et al., 2008) diseases, and skeletal muscle disorders (Iannotti e al., 2010; Iannotti et al., 2013) . However, most of available synthetic compounds discriminated poorly among K v 7 channels formed by distinct combinations of K v 7.2-5 subunits (Xiong et al., 2008) . Therefore, compounds showing increased K v 7 subtypeselectivity, beside representing important probes to elucidate the molecular pathophysiology of K v 7 channels at distinct sites, may offer additional therapeutic benefits (Wickenden et al., 2008) .
Scorpion venoms are a large source of peptides active on K + channels (KTx's) (Rodriguez de la Vega and Possani, 2004) . According to their size, KTx's can be classified into short chain toxins (αKTx's), consisting of 23-42 amino acids peptides stabilized by 3 or 4 disulfide bridges (Tytgat et al., 1999) , and long chain toxins (β-KTx's) of 45-75 residues stabilized by 3 disulfide bridges . Two structurally distinct domains can be recognized in β -
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KTx's: a putatively α-helical N terminus, and a cysteine-rich C-terminal domain containing a common structural motif named Cs-α/β for cysteine-stabilized α-helix/β-sheet (Zhu et al., 2004) .
Remarkably, venom peptides mostly act as K + channel blockers, whereas naturally-occurring K + channel activators have been rarely found.
Several KTx's have been described in Androctonus scorpion species. These include α KTx's, such as kaliotoxin (KTX) (Crest et al., 1992) and kaliotoxin-2 (KTX2) (Laraba-Djebari et al., 1994) , and, among βKTx's, AaTXKβ . Therefore, the aim of the present work has been to investigate the from Androctonus Australis (Aa) scorpion venom as a potential source of novel molecular entities active on K v 7 channels. We report the biochemical and electrophysiological characterization of AaTXKβ , a novel molecular variant of AaTXKβ, as the first peptide activator of K v 7.4 channels, also acting as a subtype-selective activator of channels formed by K v 7.3, K v 7.2/3, K v 7.5/3 subunits.
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Materials and Methods
Materials
Trypsin, α-cyano-4-hydroxycinnamic acid, dithiothreitol and NH 4 HCO 3 were from Sigma (St. Louis, MO, USA). Trifluoroacetic acid (TFA)-HPLC grade was from Carlo Erba (Milan, Italy).
Retigabine (N-(2-Amino-4-(4-fluorobenzylamino)-phenyl)-carbamic acid ethyl ester) was from Valeant Pharmaceuticals (Aliso Viejo, CA, USA). All other reagents and solvents were of the highest purity available (J.T. Baker, Phillipsburg, NJ, USA).
Scorpion venom
Venom of Androctonus australis (Aa) was collected from Beni Khedach (Tunisia) by the veterinarian service of the Pasteur Institute of Tunis and kept frozen at -20 °C in its crude form until use.
Purification procedures
Crude venom was dissolved in water and loaded on Sephadex G50 gel filtration chromatography columns (2 x K26/100; Pharmacia). Columns were equilibrated and eluted with 0.1 M acetic acid buffer, pH 4.7. After freeze-drying, the resolved fractions were stored at -20°C until use. The elution profile of M2Aa was eventually collected in 4 sub-fractions (M2a, M2b, M2c, and M2d). HPLC purification of M2c was performed using a C8 reversed-phase HPLC column (5µm, 4.6x250mm, Beckman Coulter, Brea, CA, USA) equipped with a Beckman series 125 pump and Beckman diode array detector set at 214 and 280 nm. Elution was controlled by means of the GOLD software (32 Karat version 7.0, Beckman Coulter), at a rate of 0.8 ml/min using a linear gradient (30 min) from 20 to 50% of solution B (0.1% TFA in acetonitrile (ACN)) in solution A (0.1% TFA in water). Protein concentration was measured by the Bradford protein assay (Fermentas, Cornaredo, Italy) using bovine serum albumin as a standard.
cRNA transcription
The cDNA encoding for human K v 7.4 was cloned in the Xenopus oocyte expression vector pTLN. After linearization with HpaI, capped cRNA was transcribed in vitro using the SP6 mMessage mMachine kit (Ambion, Foster City, CA, USA).
Expression in Xenopus laevis oocytes
This article has not been copyedited and formatted. The final version may differ from this version. were activated with voltage pulses from -100 to +40 mV in 10 mV steps, followed by a constant pulse to -120 mV of 300 ms duration.
Patch clamp
Currents from CHO cells were recorded at room temperature (20-22°C) using the whole- either by 1.5 sec depolarizing pulses from -80 mV to +40 mV in +10 mV increments, followed by an isopotential pulse at 0 mV of 500 ms duration, or by 3-sec voltage ramps from -80 mV to +20 mV applied at 0.08 Hz frequency. Current were recorded using an Axopatch-200A amplifier, filtered at 5 kHz, and digitized using a DigiData 1440A (Molecular Devices, Union City, CA, USA). The pCLAMP software (version 10.2) was used for data acquisition and analysis (Molecular Devices, Union City, CA).
Electrophysiological data analysis
For K v 7.4 currents in Xenopus oocytes, whole-cell conductance (G) was calculated according to the following equation: G=Imax/(V-E K ), where I is the steady-state current measured at the end of each depolarizing step, V is the step potential, and E K is the reversal potential for potassium, which was calculated to be -98 mV. Conductance values were expressed as a function of membrane potential, and fit to a single Boltzmann distribution of the following form:
where V is the test potential, V 1/2 is the half-activation potential, and k is the slope factor (Wickenden et al., 2008) .
For K v 7.4 currents in CHO cells, conductance-voltage (activation) curves were generated by normalizing to the maximal value of the instantaneous isopotential currents at 0 mV, and expressing the normalized values as a function of the preceding voltages. Data were fit to a sum of two
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independent Boltzmann distributions (B 1 and B 2 ) of the following form:
where V is the test potential, V 1 and V 2 the half-activation potentials, k 1 and k 2 the slopes, and max 1 and max 2 the relative amplitudes for each Boltzmann distribution (Castaldo et al., 2002) . Ramp-evoked currents were analyzed by measuring the currents at -40 mV (a membrane potential value close to the activation threshold) and at 0 mV (a membrane potential value at which K v 7.4 conductance is largely saturated), and the effect of each venom fraction was expressed as the percent of current increase at these two membrane voltages. Data analysis and fit were performed using the Origin software (version 8.0; OriginLab, Northampton, MA, USA).
Disulfide bridges reduction and enzymatic hydrolysis
HPLC purified venom fractions were dissolved in 50 mM NH 4 HCO 3 buffer at pH 8.0, and dithiothreitol (DTT) was added to a final concentration of 2 mM. Samples were allowed to react at 37°C for 2 h. Enzymatic digestion was then performed by adding trypsin with an enzyme/substrate ratio of 1/50 w/w at 37 °C for 16 h in the presence of DTT.
MALDI Mass Spectrometry
MALDI-MS experiments were performed on a Voyager-DE STR MALDITOF mass
spectrometer (Applied Biosystems, Framingham, MA, USA) equipped with a nitrogen laser (337 nm). 1 μl of the sample was mixed (1/1, v/v) with a 10 mg/ml solution of α-cyano-4-hydroxycinnamic acid in ACN/50 mM citrate buffer, 70/30 v/v. Spectra were acquired using a mass (m/z) range of 400-5000 amu for Peptide Mass Fingerprint and 3000-8000 amu for molecular weight determination.
TANDEM mass spectrometry.
The peptide mixtures were filtered using 0.22 µm PVDF membrane (Millipore) and analysed using a 6520 Accurate-Mass Q-TOF LC/MS System equipped with a 1200 HPLC system and a chip cube (Agilent Technologies, Palo Alto, CA, USA). After sample loading, the peptide mixture was first concentrated and washed on 40 nl enrichment column (Agilent Technologies chip), with 0.1% formic acid in 2% ACN as the eluent. The sample was then fractionated on a C18
reverse-phase capillary column at flow rate of 400 nl/min, with a linear gradient of eluent B (0.1% formic acid in 95% ACN) in A (0.1% formic acid in 2% ACN) from 7 to 80% in 50 min. Peptide analysis was performed using data-dependent acquisition of one MS scan (mass range from 300 to 1800 m/z) followed by MS/MS scans of the five most abundant ions in each MS scan. Dynamic exclusion was used to acquire a more complete survey of the peptides by automatic recognition and
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1 0 temporary exclusion (0.5 min) of ions from which definitive mass spectral data had been previously acquired. Nitrogen at a flow rate of 3 L/min and heated to 325°C was used as the dry gas for spray desolvation. MS/MS spectra were measured automatically when the MS signal surpassed the threshold of 50000 counts. Double and triple charged ions were preferably isolated and fragmented over single charged ions.
Protein identification
The acquired MS/MS spectra were transformed in mz.data format and used for proteins identification with a licensed version of MASCOT 2. Spectra with a MASCOT score < 25 having low quality were rejected.
Single Ion Monitoring analysis.
Peptide mixtures, obtained as previously described, were analysed by LC-MS/MS using a 4000QTrap (Applied Biosystems, Framingham, MA, USA) coupled to a NanoLC-2D Plus system equipped with a cHiPLC®-Nanoflex System (Eksigent, Dublin, CA, USA). The mixture was loaded on an Eksigent Nano cHiPLC Trap column (200µm x 0.5mm ChromXP C18-CL 3 µm 300Å) at 2 μl/min (A solvent 0.1% formic acid, loading time 10 min). Peptides were separated on an Eksigent reverse-phase Nano cHiPLC column (75 µm x 15 cm ChromXP C18-CL 3 µm 120Å), at a flow rate of 0.3 μl/min with a 5 to 65% linear gradient in 60 min (A solvent 0.1% formic acid, 2% ACN in water; B solvent 0.1% formic acid, 2% water in ACN). Nanospray source was used at 2.8 kV with liquid coupling, with a declustering potential of 80 V, using an uncoated silica tip from Statistical differences between data groups, expressed as means±SEM, were tested using an unpaired two-tailed Student's t-test, assuming that the population follows a Gaussian distribution.
Differences were considered statistically-different vs respective controls when p<0.05.
This article has not been copyedited and formatted. The final version may differ from this version. 
Results
Effects of gel filtration-purified Aa venom fractions on K v 7.4 channels expressed in Xenopus oocytes.
To search for naturally-occurring peptides active on K v 7.4 channels from the Aa scorpion,
crude Aa venom was separated by gel filtration. The resulting profile (Fig. 1A) shows five partiallyresolved fractions; among these, four correspond to non-toxic fractions (M1, M2, M3, and M4), and one (G50) was toxic in-vivo (Miranda et al., 1970) . Fractions M1, M2 and G50, containing molecules having a molecular weight range >2 kDa, were selected for functional screening on K v 7.4 channels expressed in Xenopus oocytes by two microelectrode voltage-clamp; M3 and M4 fractions were not studied, as they contained low molecular weight material in relatively low abundance. K v 7.4 currents were activated by membrane depolarization above -40 mV, and displayed slow activation kinetics, and lack of inactivation ( G/V relationships (n=5; p>0.05). Both these effects were largely reversible after 5 min washout of the M2 fraction. The effect of M2 on K v 7.4 channels was dose-dependent between 1 and 100 µg/ml (Fig. 1D) ; higher concentrations could not be tested because of the limited material availability. In contrast to M2, perfusion with G50 (50 µg/ml) did not modify K v 7.4 currents, whereas 50 µg/ml M1 significantly decreased K v 7.4 current amplitude by 51.4±9% (Fig. 1E ). Given our interest in K v 7.4 activators rather than blockers, this latter effect was not pursued any further.
Effect of M2 sub-fractions on K v 7.4 channels expressed in mammalian cells.
The M2 fraction contains a heterogeneous mixture of molecules ranging from 7 to 12 kDa.
To achieve a better size-separation, the M2 fraction eluted from the Sephadex G-50 column was collected into 4 sub-fractions (M2a, M2b, M2c, and M2d) ( Fig. 2A) . Given the little amount of purified fractions available, the effect on K v 7.4 channels exerted by each M2 sub-fraction was then studied using the whole-cell configuration of the patch-clamp technique in mammalian cells transiently transfected with K v 7.4 cDNA; this strategy allowed to use much less material than that
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1 3 required for Xenopus oocytes experiments. In addition, to decrease the length of each experiment and further reduce the amount of material needed, we tested the effects of the four M2 sub-fractions using a voltage protocol in which K v 7.4 currents were activated by 3-sec voltage ramps from -80 mV to +20 mV applied at 0.08 Hz frequency. Perfusion with 50 µg/ml of the M2c sub-fraction, corresponding to the descending flank of the M2 fraction ( Fig. 2A) , enhanced ramp-evoked K v 7.4 currents (Fig. 2B ). As shown in Fig. 2C , the extent of K v 7.4 current enhancement by M2c was larger at -40 mV (+44.4±3.8%) than at 0 mV (+24.5±1.7%), thus largely reproducing the previously-described effects exerted by the whole M2 fraction on K v 7.4 channels expressed in Xenopus oocytes. M2c was the only M2 sub-fraction active on K v 7.4 channels; in fact, perfusion with M2a, M2b, and M2d (each at 50 µg/ml) failed to affect the threshold activation potential or the maximal current amplitude of the expressed channels (Fig. 2C) .
Effect of M2c sub-fractions on K v 7.4 channels expressed in mammalian cells.
The M2c gel filtration sub-fraction was resolved on a C8 analytical HPLC column, leading to the identification of nine peaks (P1-P9) (Fig. 3A) . When each of these purified peaks were separately tested (each at 20 µg/ml) for their effect on K v 7.4 currents by patch-clamp experiments, it was found that only P8, eluted at 19 min, enhanced K v 7.4 currents (Fig. 3B) . Again, as already observed for the whole M2 fraction and the M2c sub-fraction, P8 effectively increased K v 7.4 currents at every potential tested, although the enhancement was more significant around membrane potential values closer to the activation threshold (-40 mV) than at 0 mV, a membrane potential value at which the K + conductance is largely saturated ( Fig. 3C ; see also Fig. 4B ). None of the other peak resulting from M2c purification modified K v 7.4 currents at -40 mV or 0 mV (Fig. 3B ). Fig. 3C shows a representative example of K v 7.4 current activation by cell perfusion with 20 µg/ml of P8, using the previously-described voltage ramp protocol.
Notably, the effects of P8 on K v 7.4 currents were qualitatively similar to those of the prototype K v 7 activator retigabine (Fig. 3B) . To compare the kinetics of onset and offset of the K v 7.4-activating effects of P8 with those of retigabine, time-course experiments were performed.
As shown in Fig. 3D , P8-induced K v 7.4 activation developed slowly, requiring about 1 minute to reach steady-state levels; similarly, basal current values were recovered after about 1 minute upon drug removal. By contrast, the kinetics of onset and offset of 10 µM retigabine appeared significantly faster, requiring less than 30 seconds to reach steady-state levels (Fig. 3D) . During the 4 min of 50 μ g/ml P8 perfusion, the maximal response decreased by an average of 14.2±4.3%
(n=8).
This article has not been copyedited and formatted. The final version may differ from this version. The voltage ramp protocol used in the previously-described experiments does not allow to precisely define the effect of the P8 fraction on the steady-state properties of the K v 7.4 conductance; therefore, in subsequent experiments, K v 7.4 channels were activated by depolarizing pulses at constant voltages. Fig. 4A shows a family of K v 7.4 currents recorded before (left panel) and after (right panel) P8 exposure. Activation curves revealed that P8 effectively increased both maximal conductance and caused a leftward shift in the activation threshold of K v 7.4 currents. In particular, experimental data analysis revealed that a sum of two Boltzmann equations (B 1 and B 2 ) was required to properly fit the data (Castaldo et al., 2002) . Under control conditions, the two Boltzmann components had a 60/40 ration in their relative amplitude (max 1 and max 2 accounted for 59±4% and 42±4% of the total conductance, respectively), and distinct half activation potentials (V 1 =-38.1±1.0 mV; V 2 =-7.3±2.1 mV) and slopes (k 1 = 9.2±0.6 mV/e-fold; k 2 = 15.0±1.3 mV/e-fold).
After P8 exposure, no significant changes were observed in the relative amplitudes (max 1 and max 2 accounted for 62±1% and 44±1% of the total conductance, respectively), nor in V 2 (-5.1±2.3 mV) or k 2 (19.2±3.6 mV/e-fold); by contrast, both V 1 (-47.7±2.4 mV) and k 1 (12.2±0.5 mV/e-fold) were significantly different from controls (n=5; p<0.05). On the other hand, retigabine failed to affect the relative amplitudes (max 1 and max 2 accounted for 66±12% and 35±12% of the total conductance, respectively), or the slopes (k 1 =11.1±1.8 mV/e-fold ; k 2 =11.1±2.2 mV/e-fold)) of B 1 and B 2 ; the midpoint potentials of both Boltzmann distribution were shifted in the hyperpolarizing direction by retigabine (V 1 =-57.5±2.1 mV; V 2 =-29.4±6.8 mV) (n=5 ; p<0.05). The inset of Fig. 4B compares the normalized activation curves for control, P8 and retigabine.
Finally, within the tested range (5-50 μg/ml), the effect of P8 on K v 7.4 current enhancement at -40 mV was concentration-dependent (Fig. 4C) .
Mass spectral analysis of the P7 and P8 fractions.
Given that P8 contained the biologically-active molecule(s) of interest, this fraction was directly submitted to MALDI-TOF mass spectrometry analysis; the same analysis was also performed on P7, which despite showing an HPLC elution profile very close to P8, was unable to modify K v 7.4 currents. MALDI-MS spectra revealed the occurrence of a major signal having a m/z value of 6991.42 (Fig. 5A ) and 7119.15 (Fig. 5B ) in P8 and P7, respectively. Both P8 and P7
fractions were subjected to disulfide bridges reduction and trypsin digestion, and the obtained peptide mixture analysed by MALDI-MS and LC-MS/MS. LC-MS/MS data analysis led to the identification in both fractions of AaTXKβ from Androctonus australis (UniProtKB P69939), whose sequence was inferred from an Aa cDNA library . Figures 5C and 5D report the P8 and P7 fractions sequence coverage obtained by
both MALDI-MS and LC-MS/MS
This article has not been copyedited and formatted. The final version may differ from this version. 6 ), searching for both peptides 1-13 (KLVKYAVPVGTLR) and 2-13 (LVKYAVPVGTLR). In P7, the presence of the signal related to peptide 1-13 and the contemporary absence of the signal related to the peptide 2-13 (Figs. 6B and 6D ) demonstrated the occurrence of the full-length AaTXKβ in this fraction. On the other hand, SIM analysis revealed the presence of the signal relative to peptide 2-13 as the major specie in P8 (Figs. 6A and 6C) . A good sequence coverage for both 2-13 and 1-13 peptides was obtained by the occurrence of intense y-ion series signals as shown in Figs. 6C and 6D. However, no signals attributable to fragment peaks that appear to extend from the amino terminus ("b ions") for both P7 and P8 peptides could be detected in the mass tandem spectra, probably due to the physicochemical characteristics of the peptides.
Since MS/MS data did not unambiguously identify the N-terminus sequences, Edman degradation of S-pyridyl-ethylated P8 and P7 was performed, leading to the identification of the Nterminal amino acid partial sequences LVKYAV and KLVKYAV in P8 and P7, respectively.
Altogether, results from molecular weight determination, mass mapping analysis, SIM analysis, and
Edman degradation strongly suggested that the P8 peptide active on K v 7.4 channels corresponds to a novel variant of AaTXKβ which lacks the N-terminal lysine; this peptide is thus called AaTXKβ . By contrast, the same experimental procedures revealed that the inactive P7 fraction corresponded to the full-length sequence of AaTXKβ (1−64) .
Only a monomeric form was observed in the mass spectra of both AaTXKβ (1−64) and AaTXKβ (2-64) polypeptides, suggesting that no intermolecular disulphide bridge were formed. These results indicate that the six cysteins of AaTXKβ and AaTXKβ are engaged in three intramolecular disulphide bridges, as previously hypothesized 
Discussion
In the present work we found that the non-toxic fraction from the venom of the North African scorpion Androctonus australis (Aa) (called M2) dose-dependently enhanced K v 7.4 currents in Xenopus oocytes, and caused a 10 mV negative shift in the midpoint potential of the activation curve. Biological activities of peptides from non-toxic venom fractions have been previously described in Buthus occitanus tunetanus scorpion venom; these include lipolytic properties (Soudani et al., 2005) , activation of nicotinic receptors in skeletal muscle cells (Cheikh et al., 2007) , and inhibition of cardiac L-type calcium currents (Cheikh et al., 2006) .
Within the 9 HPLC fractions of M2, only the sub-fraction called P8 displayed K v 7.4-activating properties. Indeed, P8 caused an increase in the maximal currents, and hyperpolarized and decreased the steepness of the activation curve of K v 7.4 channels. In P8, mass mapping data identified AaTXKβ, a long chain β -KTX whose sequence was inferred upon screening of a cDNA library from Aa venom glands . Surprisingly, same analysis performed on the P7 HPLC peak, which did not enhance K v 7.4 currents, also led to the identification of , 2008) . By contrast, no study has been carried out to isolate the corresponding peptide from Aa venom, and the activity of AaTXKβ on K + channels (or on any ion channel) has never been investigated. AaTXKβ has a high sequence similarity (~88% identity) with MeuTXKβ1 from Mesobuthus eupeus (Fig.8) , a peptide showing weak affinity for K + channels, but exhibiting anti-Plasmodial and cytolytic activities, and whose structural features have
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1 8 been resolved ( Zhu et al., 2010) . It has been suggested that, when compared to TsTXKβ , the weak affinity of MeuTXKβ1 for K + channels may be explained by its extended Nterminal domain with 9 extra residues, highlighting a critical role of this region for target recognition. AaTXKβ also lacks this N-terminal extension, and, similarly to TsTXKβ, could be a 'truncated' version of MeuTXKβ1. Notably, a critical influence of the N-terminal region for scorpion toxins interaction with K + channels has been already described for KTX2 (Legros et al., 1997) , and for HgeβKTX . Similarly, chemical modifications and mutagenesis studies have revealed that the N-terminal amino group or the N-terminal basic residues of scorpion β-neurotoxins (or both) are critical for their interaction with voltage-gated Na + channels (Polikarpov e al., 1999) .
Altogether, these data suggest that β -KTx's having the classical Cs-α/β scaffold not only produce inhibitory effects on K + channels, but can also activate ionic conductances. This ability has been previously described for martentoxin (MarTx), an α-KTx purified from the East-Asian scorpion Mesobuthus martensi venom, which enhances the activities of native and cloned BK channels (Tao et al., 2011) , and DkTx (double-knot toxin) purified from the venom of the Chinese bird tarantula Ornithoctonus huwena, which selectively and irreversibly activates transient receptor potential vanilloid-1 (TRPV1) channels (Bohlen et al., 2010) . Notably, a MarTx variant (MarTx-1)
lacking of the N-terminal phenylalanine displayed similar biological activities when compared to the full-length MarTx (Cao et al., 2003b) .
The ability of AaTXKβ to cause an hyperpolarization shift in K v 7.4 channels gating is reminiscent of the effects exerted on voltage-gated Na + channels by β-scorpion toxins acting at site 4 (Dutertre and Lewis, 2010) ; these toxins enhance voltage-dependent activation of Na + channels by modifying the movement of the S 4 segments via a voltage-sensor trapping mechanism (Catterall et al., 2007) . Toxin-induced sensor-trapping can also occur in voltage-gated Ca 2+ channels (agatoxins from spiders) (McDonough, 2007) , and in voltage-gated K + channels of the K v 2 and K v 4 (hanatoxins from tarantula) (Swartz and MacKinnon, 1997) , or K v 3 and K v 11 (sea anemone toxins) (Diochot and Lazdunski, 2009) subclasses. It has been reported that a conserved structural motif in voltage-gated K + and Ca 2+ channels can account for the "promiscuity" of both hanatoxin and grammotoxin (another tarantula toxin) to interact with both channel classes (Li-Smerin and Swartz, 1998) , and, possibly, with non-voltage gated channels of the TRPV1 sub-family (Siemens et al., 2006) . Distinct similarities and difference can be found between AaTXKβ (2-64) and previously described synthetic K v 7 channels openers. In fact, similarly to retigabine, the prototype K v 7 opener in clinical use as an anticonvulsant (Miceli et al., 2008) , AaTXKβ (2-64) hyperpolarizes the activation (Tatulian et al., 2001; Dupuis et al., 2002) . However, since these differences are quantitatively rather small, retigabine is currently regarded as a poorly selective opener for channels composed of K v 7.2-5 subunits, being instead ineffective in K v 7.1 channels. In the present experiments, in addition to homomeric K v 7.4, AaTXKβ (2-64) produced a hyperpolarizing shift in opening voltage-dependence through homomeric K v 7.3 and heteromeric K v 7.2/3 channels.
At potential above 0 mV, AaTXKβ increased the maximal current in homomeric K v 7.4 and heteromeric K v 7.2/3 and K v 7.5/3 channels, but not in homomeric K v 7.3 channels. Strikingly, both homomeric K v 7.1 and K v 7.2, as well as the distantly-related K v 1.1 channels were unaffected by AaTXKβ . In K v 7.4 channels, the effect of AaTXKβ was relatively slow compared to retigabine and largely reversible, possibly suggesting an extracellular site of action.
Multiple mechanisms might cause the subtype-selective macroscopic current increase at depolarized voltages by AaTXKβ in K v 7 channels; these include an increase in the number of functional channels, of the single channel conductance, or of the maximal channel open probability (P o ). The possibility that AaTXKβ (2-64) recruits more active channels at the plasma membrane seems unlikely, given that the toxin actions were rather fast, requiring about one minute to achieve maximal effect, and were largely reversible. Considering that most toxins acting as gating modulators of K v channels bind at a distance from the pore and do not affect single-channel conductance (Swartz and MacKinnon, 1997) , we therefore speculate that AaTXKβ increases the P o of K v 7.4 channels. Although single channel experiments were not performed to solve this issue, the fact that AaTXKβ caused an hyperpolarization shift with no significant augmentation of maximal currents in K v 7.3 channels whose maximal P o is close to unity (Li et al., 2004 ) seems in line with such speculation.
Recently, acidic scorpion toxins belonging to new κ -KTX2 and α -KTX28 subfamilies have been found to inhibit K v 7.1 channels, although they did not affect other K + channels which are canonical targets for basic KTx (such as K v 1.3); unfortunately, the pharmacological profile of these toxins for channels formed by other K v 7 subunit combination is currently unknown (Chen et al., 2012) . Other compounds with a certain degree of selectivity for K v 7 subtypes are: 1. the acrylamide derivative (S)-1 which preferentially activates K v 7.4 and K v 7.5 channels (Bentzen et al., 2006) 
2 0 potency on K v 7.4 or K v 7.3/K v 7.5 channels and no activity on K v 7.1 channels (Wickenden et al., 2008) ; 3. the diphenylamine carboxylate derivative NH29, which increases the current amplitude of K v 7.2, is weakly effective in K v 7.4, and is ineffective on K v 7.3 and K v 7.1 channels (Peretz et al., 2010) ; 4. the cysteine-alkylating agent N-ethylmaleimide, which increases the currents carried by K v 7.2, K v 7.4 or K v 7.5, but not by K v 7.1 and K v 7.3 channels (Li et al., 2004) ; 5. zinc pyrithione, which potently activates K v 7.1, K v 7.2, K v 7.4, and K v 7.5, but not K v 7.3, channels (Xiong et al., 2007) . Notably, the existence of at least two different binding regions, one in the pore and/or in the gating hinge and one in the voltage sensor itself, appears to contribute to the pharmacological profile shown by synthetic openers for distinct K v 7 subunit combinations  whether these sites also contribute to the selectivity pattern of AaTXKβ remains to be investigated.
In conclusion, in the present study, we report the isolation and functional characterization of AaTXKβ , a novel variant of AaTXKβ from the non-toxic fraction of the Androctonus australis scorpion acting as the first peptide activator of K v 7 channels. We anticipate that these results might prove useful to unravel novel biological roles of AaTXKβ (2-64) -sensitive K v 7.4 channels, and to develop novel pharmacological tools allowing subtype-selective targeting of K v 7 channels.
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